Impact of Antihyperglycemic Drugs on Asthma Outcomes: Diversifying the Research Portfolio

J Allergy Clin Immunol Pract. 2024 Aug;12(8):2045-2046. doi: 10.1016/j.jaip.2024.05.030.

Authors

Tianshi David Wu¹, Katherine N Cahill²

Affiliations

¹ Section of Pulmonary, Critical Care, and Sleep Medicine, Baylor College of Medicine, Houston, Texas; Center for Innovations in Quality, Effectiveness, and Safety, Michael E. Debakey VA Medical Center, Houston, Texas.
² Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tenn. Electronic address: [email protected].

PMID: 39122331
DOI: 10.1016/j.jaip.2024.05.030

No abstract available

Publication types

Editorial

MeSH terms

Asthma* / drug therapy
Humans
Hypoglycemic Agents* / therapeutic use
Treatment Outcome

Substances

Hypoglycemic Agents